Shah, Chirag
Whitworth, Pat
Vicini, Frank A.
Narod, Steven
Gerber, Naamit
Jhawar, Sachin R.
King, Tari A.
Mittendorf, Elizabeth A.
Willey, Shawna C.
Rabinovich, Rachel
Gold, Linsey
Brown, Eric
Patel, Anushka
Vargo, John
Barry, Parul N.
Rock, David
Friedman, Neil
Bedi, Gauri
Templeton, Sandra
Brown, Sheree
Gabordi, Robert
Riley, Lee
Lee, Lucy
Baron, Paul
Majithia, Lonika
Mirabeau-Beale, Kristina L.
Reid, Vincent J.
Hirsch, Arica
Hwang, Catherine
Pellicane, James
Maganini, Robert
Khan, Sadia
MacDermed, Dhara M.
Small, William
Mittal, Karuna
Borgen, Patrick
Cox, Charles
Shivers, Steven C.
Bremer, Troy
Funding for this research was provided by:
PreludeDx
Article History
Received: 23 January 2024
Accepted: 13 May 2024
First Online: 25 June 2024
DISCLOSURES
: Troy Bremer, Steven C. Shivers, Karuna Mittal, and Pat Whitworth are employees of, and have stock options in, PreludeDx. Troy Bremer is Chief Science Officer of PreludeDx, co-invented the technology, and is named as an inventor of DCISionRT<sup>®</sup>. Frank Vicini, Chirag Shah, and Steven Narod are consultants for PreludeDx. All other co-authors were local principal investigators for the PREDICT Registry and their institutions received research funding to cover the costs of IRB review, patient enrollment, and completion of case report forms. Frank Vicini is also a consultant for Impedimed. Sachin Jhawar received grant funding from Varian Medical Systems to study the role of the oropharyngeal microbiome in head and neck cancer patients. Tari King declares speakers honoraria and compensated advisory board from Exact Sciences; Faculty PrecisCa Cancer Information Services. John Vargo declares Consulting Elsevier Clinical Pathways. Parul Barry declares El-Sevier Pathways Consultant; Talks for Oncolive/Varian on breast cancer and women in medicine; ACRO Board Member, Chair of ASTRO HEDI Education, Chair of the WIMS Scientific Committee.